2024년에 337억 달러로 추정되는 디지털 유전체 세계 시장은 2024년부터 2030년까지 CAGR 13.7%로 성장하여 2030년에는 728억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 시퀀싱 및 분석기 기기는 CAGR 16.1%를 기록하며 분석 기간 종료까지 318억 달러에 달할 것으로 예측됩니다. DNA/RNA 어세이 키트 분야의 성장률은 분석 기간 CAGR로 11.3%로 추정됩니다.
미국 시장은 89억 달러로 추정, 중국은 CAGR 12.8%로 성장 예측
미국의 디지털 유전체 시장은 2024년에 89억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 112억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.8%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 13.0%와 11.5%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.8%로 성장할 것으로 예측됩니다.
세계 디지털 유전체 시장 - 주요 동향 및 촉진요인 정리
정밀의료는 디지털 유전체의 시대로?
디지털 유전체는 개인의 완전한 유전코드를 가상으로 표현하고 첨단 컴퓨팅 시스템을 사용하여 저장 및 분석한 것으로, 맞춤형 의료, 의약품 개발, 질병 예방의 판도를 바꾸고 있습니다. 디지털 유전체 세계 시장은 차세대 염기서열 분석기(NGS), AI를 활용한 바이오인포매틱스, 클라우드 기반 데이터 스토리지의 융합에 의해 주도되고 있으며, 신속하고 확장 가능하며 비용 효율적인 유전자 분석이 가능해졌습니다.
결정적인 트렌드는 사일로화된 유전자 검사에서 원시 DNA 데이터, 표현형 연결, 건강 기록, 실시간 모니터링을 통합된 인터페이스로 통합하는 통합 디지털 유전체 플랫폼으로 전환하는 것입니다. 이러한 플랫폼은 종양학, 희귀질환 진단, 약리유전체학, 집단유전체학 분야에서 활용이 확대되고 있습니다. 미국, 영국, 중국 등의 국가들은 국가 차원의 유전체 매핑 프로젝트에 투자하고 있으며, 데이터량이 풍부하고 클라우드에서 안전한 디지털 유전체 인프라의 채택을 촉진하고 있습니다.
기술 융합은 유전체의 가능성을 어떻게 열어줄까?
AI와 머신러닝 알고리즘은 디지털 유전체 혁명의 핵심으로, 신속한 변종 검출, 위험 모델링, 치료 표적 식별을 촉진하고 있습니다. 이러한 기술은 임상의가 복잡한 유전체 데이터세트를 해석하고 최적의 치료법을 찾아내는 데 도움을 주고 있습니다. 또한, 웨어러블에 통합된 건강 데이터를 통해 개인의 유전체 프로파일을 실시간으로 업데이트할 수 있게 되었으며, 특히 종단적 건강 조사에서 더욱 그러합니다.
저장 및 암호화 기술의 발전으로 유전자 데이터의 안전한 공유도 가능해졌습니다. 통합 데이터 모델과 블록체인은 GDPR에 기반한 EU나 HIPAA에 기반한 미국과 같은 규제 환경에서 중요한 관심사인 환자의 프라이버시를 침해하지 않고 게놈 데이터에 대한 분산화된 접근을 가능하게 하기 위해 고려되고 있습니다.
수요가 가속화되고 있는 시장과 최종사용자는?
디지털 유전체 시장은 북미와 유럽에서 빠르게 성장하고 있으며, 아시아태평양은 정부 지원 유전체 시퀀싱 프로그램과 생명공학 생태계 확대로 인해 전략적 성장의 최전선으로 부상하고 있습니다. 최종사용자에는 학술 연구기관, 병원, 바이오 제약사, 소비자 직접 판매(DTC) 유전자 검사 제공업체, 의료 보험사 등이 포함됩니다.
영국의 100,000 유전체 프로젝트나 NIH의 All of Us 연구 프로그램과 같은 인구 건강 이니셔티브가 주요 성장 촉매제인 반면, 비상장 유전자 검사 회사들은 소비자 대상 유전체 대시보드를 개발하여 유전적 위험과 생활습관 및 웰빙 개입을 연결하고 있습니다. 유전적 위험과 생활습관 및 웰빙 개입을 연결하고 있습니다.
디지털 유전체 시장의 성장 원동력은?
디지털 유전체 시장의 성장은 유전체 과학, AI 분석, 정밀의료에 대한 수요의 합류로 이루어지고 있습니다. 전장 유전체 염기서열의 가격이 상승하고 클라우드 컴퓨팅에 대한 접근이 용이해지면서 디지털 유전체 플랫폼을 채택하는 의료기관이 증가하고 있습니다.
헬스케어 시스템은 특히 종양학, 심장학, 신경학 분야에서 위험 계층화 및 조기 개입에 있어 유전체학의 가치를 인식하고 있습니다. 제약사들은 디지털 유전체 데이터세트를 활용하여 새로운 약물 타겟을 식별하고, 유전자 반응성에 따라 임상시험 참가자를 계층화하고 있습니다. 규제 명확화와 데이터 공유에 대한 세계 협력은 디지털 유전체를 주류 의학에 통합하는 것을 더욱 촉진하고 있습니다.
부문
제품(시퀀싱 및 분석기 기기, DNA/RNA 어세이 키트, 시퀀싱 칩, 시퀀싱 및 분석 소프트웨어, 샘플 조제 기기), 용도(임상, 법의학, Drug Discovery & Development, 기타 용도), 최종사용자(병원, 진단 센터 및 법의학 연구소, 연구개발, 기타 최종사용자)
조사 대상 기업 사례(총 44개사)
10x Genomics
Agilent Technologies, Inc.
ArcherDx, Inc.
BGI Genomics
bioMerieux SA
Bio-Rad Laboratories, Inc.
Eurofins Scientific SE
Fabric Genomics, Inc.
Foundation Medicine, Inc.
Genewiz
Guardant Health, Inc.
Illumina, Inc.
Invitae Corporation
Myriad Genetics, Inc.
NanoString Technologies, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.
Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.
2025년 4월 : 협상 단계
이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.
2025년 7월 : 최종 관세 재설정
고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.
상호 및 양자 간 무역과 관세의 영향 분석:
미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국
업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정을 적용하고 있습니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSM
영문 목차
영문목차
Global Digital Genomes Market to Reach US$72.8 Billion by 2030
The global market for Digital Genomes estimated at US$33.7 Billion in the year 2024, is expected to reach US$72.8 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Sequencing & Analyzer Instruments, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$31.8 Billion by the end of the analysis period. Growth in the DNA / RNA Analysis Kits segment is estimated at 11.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 12.8% CAGR
The Digital Genomes market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.
Global Digital Genomes Market - Key Trends & Drivers Summarized
Is Precision Health Entering the Age of the Digital Genome?
Digital genomes-virtual representations of an individual’s complete genetic code stored and analyzed using advanced computing systems-are transforming the landscape of personalized medicine, drug development, and disease prevention. The global market for digital genomes is being driven by the convergence of next-generation sequencing (NGS), AI-enabled bioinformatics, and cloud-based data storage, enabling rapid, scalable, and cost-effective genetic analysis.
A defining trend is the shift from siloed genetic testing to integrated digital genome platforms, which consolidate raw DNA data, phenotype linkage, health records, and real-time monitoring into unified interfaces. These platforms are finding increasing use in oncology, rare disease diagnostics, pharmacogenomics, and population genomics initiatives. Countries such as the U.S., U.K., and China are investing in national-scale genome mapping projects, boosting the adoption of data-rich, cloud-secure digital genome infrastructure.
How Are Technological Convergences Unlocking Genomic Potential?
AI and machine learning algorithms are central to the digital genome revolution, facilitating rapid variant detection, risk modeling, and therapeutic target identification. These technologies are helping clinicians interpret complex genomic datasets and match them with optimal treatments-ushering in an era of predictive and preventive medicine. Moreover, real-time updates to individual genome profiles via wearable-integrated health data are becoming possible, especially in longitudinal health studies.
Advancements in storage and encryption technologies are also making secure sharing of genetic data feasible. Federated data models and blockchain are being explored to allow decentralized access to genomic data without compromising patient privacy, a key concern in regulated environments like the EU under GDPR or the U.S. under HIPAA.
Where Is Demand Accelerating and Who Are the End-Users?
The digital genome market is expanding rapidly in North America and Europe, with Asia-Pacific emerging as a strategic growth frontier due to government-backed genome sequencing programs and expanding biotech ecosystems. End-users include academic research institutions, hospitals, biopharmaceutical companies, direct-to-consumer (DTC) genetic testing providers, and health insurers.
Population health initiatives-such as the UK's 100,000 Genomes Project or the NIH's All of Us research program-are key growth catalysts, while private genetic testing companies are deploying consumer-facing genome dashboards to connect genetic risk with lifestyle and wellness interventions.
What’s Driving Growth in the Digital Genomes Market?
The growth in the digital genomes market is driven by a confluence of genomic science, AI analytics, and demand for precision medicine. Rising affordability of whole genome sequencing, along with increased accessibility to cloud computing, is enabling more institutions to adopt digital genome platforms.
Healthcare systems are recognizing the value of genomics in risk stratification and early intervention, particularly in oncology, cardiology, and neurology. Pharmaceutical firms are using digital genome datasets to identify novel drug targets and stratify trial participants based on genetic responsiveness. Regulatory clarity and global collaborations on data sharing are further fueling the integration of digital genomes into mainstream medicine.
SCOPE OF STUDY:
The report analyzes the Digital Genomes market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments); Application (Clinical, Forensics, Drug Discovery & Development, Other Applications); End-User (Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 44 Featured) -
10x Genomics
Agilent Technologies, Inc.
ArcherDx, Inc.
BGI Genomics
bioMerieux SA
Bio-Rad Laboratories, Inc.
Eurofins Scientific SE
Fabric Genomics, Inc.
Foundation Medicine, Inc.
Genewiz
Guardant Health, Inc.
Illumina, Inc.
Invitae Corporation
Myriad Genetics, Inc.
NanoString Technologies, Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Digital Genomes - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Advances in Genomic Sequencing Technologies Propel Demand for Digital Genome Platforms
Rising Use of AI in Genomic Data Interpretation Accelerates Clinical Application of Digital Genomes
Personalized Medicine Trends Strengthen Business Case for Genome Digitization
Integration of Genomic Data with EHR Systems Enhances Predictive Healthcare Models
Growing Demand for Population-Wide Genomic Screening Expands Digital Genome Infrastructure Investment
Increased Focus on Rare Disease Diagnosis Drives Adoption of Comprehensive Genomic Databases
Data Privacy Regulations in Genomics Create Both Challenges and Opportunities for Secure Platform Development
Collaborations Between Biotech Firms and Cloud Providers Spur Innovation in Scalable Genome Data Storage
Pharma R&D Shifts Toward Genotype-Driven Drug Discovery Highlights Need for Digital Genome Platforms
Public Health Genomics Programs in Asia and Europe Generate Long-Term Growth Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Digital Genomes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Sequencing & Analyzer Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Sequencing & Analyzer Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for DNA / RNA Analysis Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for DNA / RNA Analysis Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Sequencing Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Sequencing Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Sequencing & Analysis Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Sequencing & Analysis Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Sample Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Sample Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers & Forensic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Diagnostic Centers & Forensic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 30: USA Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 31: USA 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: USA 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 34: USA Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: USA 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
CANADA
TABLE 36: Canada Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 37: Canada 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 40: Canada Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: Canada 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
JAPAN
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 42: Japan Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: Japan 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 46: Japan Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: Japan 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
CHINA
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 48: China Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: China 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: China 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 52: China Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: China 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
EUROPE
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 54: Europe Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 55: Europe 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 58: Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 60: Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
FRANCE
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: France 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 64: France Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: France 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 66: France Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: France 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
GERMANY
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Germany 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 70: Germany Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 71: Germany 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 72: Germany Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: Germany 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Italy 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 76: Italy Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: Italy 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 78: Italy Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: Italy 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
UNITED KINGDOM
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: UK 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 82: UK Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: UK 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 84: UK Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: UK 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Rest of Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
ASIA-PACIFIC
Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Asia-Pacific 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 95: Asia-Pacific 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 97: Asia-Pacific 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
REST OF WORLD
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Rest of World 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
TABLE 100: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 101: Rest of World 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
TABLE 102: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 103: Rest of World 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
